Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2025-12-24 @ 11:36 PM
NCT ID:
NCT07072156
Eligibility Criteria:
Inclusion Criteria:
* Stage 2A-2B breast cancer
* Receiving neoadjuvant chemotherapy
* On a chemotherapy protocol administered every 21 days
* Receiving second or subsequent chemotherapy cycle
* No migraine, vertigo, active nausea, vomiting, or headache
* No history of seizures
* No primary or metastatic brain cancer
* No visual, hearing, or cognitive impairment
* Age 18 or older
* No communication barriers
* Voluntary participation
Exclusion Criteria:
* Cancer types other than breast cancer
* Unilateral or bilateral mastectomy
* Any condition preventing hand use (e.g., pain, fracture, open wound)
* IV access in both arms
* Psychiatric diagnosis
* Diagnosed anxiety disorder or current anti-anxiety medication use
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT07072156
Study Brief:
Protocol Section:
NCT07072156